Skip to content

SXTPW 60 DEGREES PHARMACEUTICALS I

Follow

*W EXP 07/12/202 (warrant or right), issuer CIK 1946563

8 managers (8 13F filers) reported a position in SXTPW shares at 2024-12-31, 631,573 shares in all. 0 filers opened a position and 1 filer sold out during the quarter.

Managers
8
13F filers
8
New
0
Added
2
Reduced
2
Sold out
1
Shares held by filers
631,573

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q4 2024

Filers in the available 13F reports with a share position at 2024-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Walleye Capital LLCin group Walleye Capital LLC222,906$6.62K<0.01%013F-HRTimelineGroup
SABBY MANAGEMENT, LLC161,930$4.81K0.04%-109,19813F-HRTimeline
CLEAR STREET LLC146,387$4.35K<0.01%-13213F-HR/ATimeline
CITADEL ADVISORS LLCin group CITADEL ADVISORS LLC47,675$1.71K<0.01%+1,40213F-HRTimelineGroup
TORNO CAPITAL, LLC47,169$1.4K<0.01%013F-HR/ATimeline
Federation des caisses Desjardins du Qu…5,000$150<0.01%013F-HRTimeline
UBS Group AGin group UBS Group AG506$15<0.01%+42613F-HRTimelineGroup
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$00%013F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.